RxDoctor Payments Data

Rebecca Brightman

Obstetrics & Gynecology · Ny, NYNPI 1184720443

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $71,655 of the $109,432 with a category attached, or 65.5%. 16 manufacturers reported payments, led by Therapeuticsmd, Inc. at 52.1% of the total. Reporting peaked in 2019 at $34,337 and has fallen 90.7% since, to $3,183 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$109,432in general payments, 2019–2025

Across 138 payments — averaging $792.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Therapeuticsmd, Inc.$57K
  • AbbVie$30K
  • Astellas Pharma US Inc$18K
  • Bayer$2K
  • Astellas Pharma Global Development$2K
  • AMAG Pharmaceuticals, Inc.$669
  • plus $623 from 10 others

What the payments were for

  • Consulting fees$71,65565%
  • Speaking & faculty fees$30,20828%
  • Travel & lodging$3,2493%
  • Food & beverage$3,6913%
  • Education$6291%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$109,432 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EstringEstradiol38$19,811
Estradiol178$19,231
ImvexxyEstradiol20$10,909
YuvafemEstradiol44$7,205
Estradiol (Twice Weekly)Estradiol41$6,209
VagifemEstradiol12$6,105
DuaveeEstrogens,conj/Bazedoxifene18$4,690
DottiEstradiol13$1,999
ProgesteroneProgesterone, Micronized31$1,139
ValacyclovirValacyclovir Hcl21$745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEstring, Duavee$37$24,50156 claims
Therapeuticsmd, Inc.Imvexxy$57,027$10,90920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

Other obstetrics & gynecology in Ny

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →